Additional file 1: Table S1. of Risk of cardiovascular events from current, recent, and cumulative exposure to abacavir among persons living with HIV who were receiving antiretroviral therapy in the United States: a cohort study Kunchok Dorjee Sanjiv Baxi Arthur Reingold Alan Hubbard 10.6084/m9.figshare.c.3915934_D1.v1 https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_Table_S1_of_Risk_of_cardiovascular_events_from_current_recent_and_cumulative_exposure_to_abacavir_among_persons_living_with_HIV_who_were_receiving_antiretroviral_therapy_in_the_United_States_a_cohort_study/5548132 ICD-9-CM and CPT codes for defining various covariates and outcomes. Table S2. Age-specific incidence rate (IR) of acute myocardial infarction (AMI) among persons living with HIV receiving antiretroviral therapy. Table S3. Factors associated with initiation of abacavir among persons living with HIV, by pooled logistic regression. Table S4 The influence of various risk factors on the development of CVD among persons living with HIV receiving anti-retroviral therapy. Table S5 Risk of CVD from current exposure to abacavir in sub-groups of variables at baseline (test of interactions). Table S6 Risk of cardiovascular disease from exposure to abacavir among persons living with HIV free of heart diseasea or substance or alcohol abuse at baseline. Appendix 1. Detailed approach to developing marginal structural models. (DOCX 58 kb) 2017-10-27 05:00:00 HIV Abacavir Anti-retroviral therapy Cardiovascular disease